Evidence map›Paper›PMID 29058724›Full record

ArticleNature chemical biology2017

A CRISPR screen identifies a pathway required for paraquat-induced cell death.

Colleen R Reczek, Kıvanç Birsoy, Hyewon Kong, Inmaculada Martínez-Reyes, Tim Wang, Peng Gao, David M Sabatini, Navdeep S Chandel

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 182 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Triaptosis and Cancer: Next Hope?Research (Washington, D.C.) · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Colleen R ReczekDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Kıvanç BirsoyLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York, USA.
Hyewon KongDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Inmaculada Martínez-ReyesDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Tim WangWhitehead Institute for Biomedical Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Peng GaoMetabolomics Core Facility, Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.
David M SabatiniWhitehead Institute for Biomedical Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Navdeep S ChandelDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Northwestern University · USBroad Institute · USRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversityRockefeller University · USWhitehead Institute for Biomedical Research · US

Funding

Tissue resident macrophages regulate proteostasis in the aging lungP01AG049665 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GR Scott Budinger · 2015 to 2026
$26.9M
Training Program In Lung SciencesT32HL076139 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KAREN M RIDGE, Jacob I Sznajder · 2004 to 2026
$9.6M
CARCINOGENESIS TRAINING PROGRAMT32CA009560 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Kathleen Janee Green · 1986 to 2026
$8.4M
Mitochondrial metabolism and ROS regulate cancerR35CA197532 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHANDEL, NAVDEEP S · 2016 to 2022
$6.3M
Metabolic liabilities of cancer cells to the tumor nutrient environmentK22CA193660 · NCI · ROCKEFELLER UNIVERSITY · PI BIRSOY, KIVANC · 2016 to 2018
$542k
NCI NIH HHS K22 CA193660NCI NIH HHS R35 CA197532NCI NIH HHS T32 CA009560NHLBI NIH HHS T32 HL076139NIA NIH HHS P01 AG049665
6 · The paper itself

Abstract

Paraquat, a herbicide linked to Parkinson's disease, generates reactive oxygen species (ROS), which causes cell death. Because the source of paraquat-induced ROS production remains unknown, we conducted a CRISPR-based positive-selection screen to identify metabolic genes essential for paraquat-induced cell death. Our screen uncovered three genes, POR (cytochrome P450 oxidoreductase), ATP7A (copper transporter), and SLC45A4 (sucrose transporter), required for paraquat-induced cell death. Furthermore, our results revealed POR as the source of paraquat-induced ROS production. Thus, our study highlights the use of functional genomic screens for uncovering redox biology.

Indexed as

Cell DeathClustered Regularly Interspaced Short Palindromic RepeatsDose-Response Relationship, DrugHumansJurkat CellsMolecular StructureOxidation-ReductionParaquatReactive Oxygen SpeciesStructure-Activity RelationshipParaquatReactive Oxygen Species

Identifiers

PMID29058724
PMCPMC5698099
OpenAlexW2765183531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.